Psychiatry and Neurology, Neurology · Williamsville, NY
NPI
1770780850
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
400 International Dr.
Williamsville, NY, 14221
Phone (716) 631-3555
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
434 services
Medicare patients, 2024
137
Average age 65
Drug cost, 2024
$2.1M
5,057 prescriptions
Company payments, 2025
$2,255
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Giglio was code 99214 (office e&m - established), 152 times for 82 patients. In total Michael A Giglio billed 434 services in 26 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 152 | 82 | $88.47 | $13K |
| 95886 Electrical Nerve Conductivity | Office | 74 | 31 | $70.04 | $5,183 |
| 99215 Office E&M - Established | Office | 38 | 35 | $127.85 | $4,858 |
| 95913 Electrical Nerve Conductivity | Office | 33 | 30 | $209.13 | $6,901 |
| 96138 Behavioral Health Services | Office | 23 | 21 | $24.40 | $561 |
| 96132 Behavioral Health Services | Office | 23 | 22 | $98.29 | $2,261 |
| 99213 Office E&M - Established | Office | 19 | 18 | $46.54 | $884 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 18 | 17 | $24.60 | $443 |
| 99205 Office E&M - New | Office | 15 | 15 | $167.39 | $2,511 |
By year: 2022 $51K for 675 services; 2023 $46K for 552 services; 2024 $40K for 434 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Giglio prescribed most often to Medicare patients was Gabapentin, with 428 prescriptions and refills. In total Michael A Giglio wrote 5,057 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 428 | 517 | 68 | $7,886 |
| Nurtec Odt Rimegepant Sulfate | 301 | 301 | 56 | $371K |
| Levetiracetam Generic | 283 | 340 | 34 | $7,221 |
| Aimovig Autoinjector Erenumab-Aooe | 229 | 243 | 28 | $178K |
| Topiramate Generic | 216 | 276 | 30 | $1,791 |
| Amitriptyline Hcl Generic | 181 | 210 | 27 | $1,710 |
| Emgality Pen Galcanezumab-Gnlm | 175 | 182 | 24 | $127K |
| Tizanidine Hcl Generic | 168 | 168 | 27 | $805 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 159 | 215 | 31 | $154K |
| Donepezil Hcl Generic | 150 | 219 | 32 | $1,098 |
| Pregabalin Generic | 148 | 148 | 25 | $2,500 |
| Ubrelvy Ubrogepant | 122 | 122 | 30 | $184K |
| Rizatriptan Rizatriptan Benzoate | 112 | 118 | 19 | $1,557 |
| Ropinirole Hcl Generic | 111 | 137 | 18 | $1,828 |
| Naratriptan Hcl Generic | 97 | 99 | 16 | $1,828 |
Brand drugs: 1,363 claims; generic drugs: 3,681 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Giglio $2,255 ($2,255 in general payments such as food, travel and fees) from 27 companies. The largest payer was Amgen Inc. with $428.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 23 | $428 |
| Pfizer Inc. PFE | 25 | $382 |
| Collegium Pharmaceutical, Inc. COLL | 20 | $212 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $140 |
| Abbvie Inc. ABBV | 5 | $119 |
| Amneal Pharmaceuticals LLC AMRX | 5 | $112 |
| Eisai Inc. 4523.T | 4 | $96.01 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $83.97 |
| MDD US Operations, LLC | 3 | $72.17 |
| Averitas Pharma Inc. | 3 | $69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.